AAAAAA

   
Results: 1-12 |
Results: 12
SAFETY AND TOLERABILITY OF THE FREE-RADICAL SCAVENGER OPC-14117 IN HUNTINGTONS-DISEASE
Authors: SHOULSON I PENNEY J KIEBURTZ K OAKES D CHASE T CHOI D MARDER K MOSKOWITZ C ZUBIN N VENTURA P FEIGIN A HICKEY C COMO P RICHARD IH GOLDSTEIN J HERSCH S BISSEYBLACK C JONES R SWENSON M BELL J PAULSEN JS SWENSON A TAWFIKREEDY Z ORME C PLUMB S RUDOLPH A CLAUDE K MCMULLEN N DAY D MARSHALL FJ BOURGEOIS K WATTS A TARIOT PN JACKSON WJ HALL WJ MADDREY W BIZIERE K JAFFE M
Citation: I. Shoulson et al., SAFETY AND TOLERABILITY OF THE FREE-RADICAL SCAVENGER OPC-14117 IN HUNTINGTONS-DISEASE, Neurology, 50(5), 1998, pp. 1366-1373
EXECUTIVE DYSFUNCTION IN TOURETTE-SYNDROME - THE ROLE OF COMORBIDITY
Authors: PALUMBO D MAUGHAN A COMO P KURLAN R
Citation: D. Palumbo et al., EXECUTIVE DYSFUNCTION IN TOURETTE-SYNDROME - THE ROLE OF COMORBIDITY, Archives of clinical neuropsychology, 12(4), 1997, pp. 380-380
DISCRIMINANT VALIDITY OF NEUROPSYCHOLOGICAL TESTING AND SYMPTOM RATING-SCALES IN DIAGNOSING ADULT ATTENTION-DEFICIT DISORDER
Authors: PALUMBO D COMO P PORTER J BARBANO R GIANG D SILVERSTEIN S
Citation: D. Palumbo et al., DISCRIMINANT VALIDITY OF NEUROPSYCHOLOGICAL TESTING AND SYMPTOM RATING-SCALES IN DIAGNOSING ADULT ATTENTION-DEFICIT DISORDER, Archives of clinical neuropsychology, 11(5), 1996, pp. 430-431
A CONTROLLED TRIAL OF REMACEMIDE HYDROCHLORIDE IN HUNTINGTONS-DISEASE
Authors: KIEBURTZ K FEIGIN A MCDERMOTT M COMO P ABWENDER D ZIMMERMAN C HICKEY C ORME C CLAUDE K SOTACK J GREENAMYRE JT DUNN C SHOULSON I
Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF REMACEMIDE HYDROCHLORIDE IN HUNTINGTONS-DISEASE, Movement disorders, 11(3), 1996, pp. 273-277
ASSESSMENT OF COENZYME-Q10 TOLERABILITY IN HUNTINGTONS-DISEASE
Authors: FEIGIN A KIEBURTZ K COMO P HICKEY C CLAUDE K ABWENDER D ZIMMERMAN C STEINBERG K SHOULSON I
Citation: A. Feigin et al., ASSESSMENT OF COENZYME-Q10 TOLERABILITY IN HUNTINGTONS-DISEASE, Movement disorders, 11(3), 1996, pp. 321-323
UNIFIED HUNTINGTONS-DISEASE RATING-SCALE - RELIABILITY AND CONSISTENCY
Authors: KIEBURTZ K PENNEY JB COMO P RANEN N SHOULSON I FEIGIN A ABWENDER D GREENAMYRE JT HIGGINS D MARSHALL FJ GOLDSTEIN J STEINBERG K SHIH C RICHARD I HICKEY C ZIMMERMAN C ORME C CLAUDE K OAKES D SAX DS KIM A HERSCH S JONES R AUCHUS A OLSEN D BISSEYBLACK C RUBIN A SCHWARTZ R DUBINSKY R MALLONEE W GRAY C GODFREY N SUTER G SHANNON KM STEBBINS GT JAGLIN JA MARDER K TAYLOR S LOUIS E MOSKOWITZ C THORNE D ZUBIN N WEXLER N SWENSON MR PAULSEN J SWERDLOW N ALBIN R WERNETTE C WALKER F HUNT V ROOS RAC YOUNG AB KOROSHETZ W BIRD E MEYERS R CUDKOWICZ M GUTTMAN M STCYR J BURKHOLDER J LUNDIN A ASHIZAWA T JANKOVIC J SIEMERS E QUAID K MARTIN W SANCHEZRAMOS J FACCA A REY G SUCHOWERSKY O ROHS G KLINEK ML ROSS C BYLSMA FW SHERR M HAYDEN M RAYMOND L CLARK C KREMER B
Citation: K. Kieburtz et al., UNIFIED HUNTINGTONS-DISEASE RATING-SCALE - RELIABILITY AND CONSISTENCY, Movement disorders, 11(2), 1996, pp. 136-142
A CONTROLLED TRIAL OF DEPRENYL IN CHILDREN WITH TOURETTES-SYNDROME AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER
Authors: FEIGIN A KURLAN R MCDERMOTT MP BEACH J DIMITSOPULOS T BROWER CA CHAPIESKI L TRINIDAD K COMO P JANKOVIC J
Citation: A. Feigin et al., A CONTROLLED TRIAL OF DEPRENYL IN CHILDREN WITH TOURETTES-SYNDROME AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER, Neurology, 46(4), 1996, pp. 965-968
FUNCTIONAL DECLINE IN HUNTINGTONS-DISEASE
Authors: FEIGIN A KIEBURTZ K BORDWELL K COMO P STEINBERG K SOTACK J ZIMMERMAN C HICKEY C ORME C SHOULSON I
Citation: A. Feigin et al., FUNCTIONAL DECLINE IN HUNTINGTONS-DISEASE, Movement disorders, 10(2), 1995, pp. 211-214
A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY OF DEPRENYL IN CHILDREN WITH TOURETTES-SYNDROME (TS) AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)
Authors: FEIGIN A KURLAN R MCDERMOTT M DIMITSOPULOS T TRINIDAD K COMO P BEACH J CHAPIESKI L JANKOVIC J
Citation: A. Feigin et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY OF DEPRENYL IN CHILDREN WITH TOURETTES-SYNDROME (TS) AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD), Neurology, 45(4), 1995, pp. 254-255
EVIDENCE OF THE GLUTAMATE ANTAGONIST REMACEMIDE HYDROCHLORIDE IN HUNTINGTONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M MARSHALL FJ FEIGIN A COMO P ABWENDER D ZIMMERMAN C HICKEY C ORME C BORDWELL K SOTACK J GREENAMYRE JT DUNN C SHOULSON I
Citation: K. Kieburtz et al., EVIDENCE OF THE GLUTAMATE ANTAGONIST REMACEMIDE HYDROCHLORIDE IN HUNTINGTONS-DISEASE, Neurology, 45(4), 1995, pp. 254-254
THE EFFECT OF DEPRENYL AND TOCOPHEROL ON COGNITIVE PERFORMANCE IN EARLY UNTREATED PARKINSONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M COMO P GROWDON J BRADY J CARTER J HUBER S KANIGAN B LANDOW E RUDOLPH A SAINTCYR J STERN Y TENNIS M THELEN J SHOULSON I
Citation: K. Kieburtz et al., THE EFFECT OF DEPRENYL AND TOCOPHEROL ON COGNITIVE PERFORMANCE IN EARLY UNTREATED PARKINSONS-DISEASE, Neurology, 44(9), 1994, pp. 1756-1759
AN OPEN-LABEL TRIAL OF COENZYME-Q10 (COQ) IN HUNTINGTONS-DISEASE (HD)
Authors: FEIGIN A KIEBURTZ K COMO P ABWENDER D ZIMMERMAN C HICKEY C STEINBERG K BORDWELL K SOTACK J ORME C SHOULSON I
Citation: A. Feigin et al., AN OPEN-LABEL TRIAL OF COENZYME-Q10 (COQ) IN HUNTINGTONS-DISEASE (HD), Neurology, 44(4), 1994, pp. 10000397-10000398
Risultati: 1-12 |